Patients with Medicare Part D insurance plans experience uneven and “restrictive” coverage of certain drugs and drug classes ...
The pharma giant and medical device maker has worked to corner the market for multiple myeloma.
XDA Developers on MSN
These 4 tools make using multiple monitors so much nicer on Windows
Stop struggling with multiple monitors.
Researchers from Brown’s Warren Alpert Medical School discussed an emerging contributor to overdose deaths in America.
Milesight, a leading provider of innovative IoT products, announced the launch of the EG71 Building IoT Gateway, designed to address ...
Persistence Market Research, a leading management consulting firm, has released this update on the EV battery management system (BMS) market. These critical systems monitor, protect, and optimize ...
We are exiting our position in Bristol Myers Squibb , selling 1,100 shares at roughly $58.94. In addition, we are initiating ...
Why smarter charging, battery management, and power conversion are now the real differentiators in EVs and edge systems.
Zongertinib provided substantial clinical benefit for patients with advanced or metastatic HER2-mutant advanced non-small cell lung cancer, surpassing the historical standard of care efficacy for this ...
Data from readily available sensors can be used to digitally trial new systems – all without risking resources.
Bristol Myers Squibb’s mezigdomide has scored its first phase 3 win, with the Cereblon E3 ligase modulator (CELMoD) tied to a statistically significant improvement in progression-free survival (PFS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results